#amyloidPET
From #amyloidPET and #radioisotope supply to #EUstrategy and #MDR, the EU Affairs Track sessions at #EANM26 offer insights into developments that are relevant to our field.

Check out the schedule 👉 https://eanm.org/eu-global-affairs/eanm26/
September 18, 2026 at 6:00 AM
Early perfusion #AmyloidPET shows great potential for diagnosing and monitoring neurodegenerative disease and may have advantages over FDG-PET, #EANM authors say. buff.ly/ByQwHG6 #NucMed #radiology
October 22, 2025 at 8:38 AM
Meta-analysis: #Centiloid values <11 or >26 on #AmyloidPET scans provide high diagnostic confidence for the absence or presence of amyloid in #AlzheimerDisease, while values between 11 and 26 indicates uncertainty and may require further assessment.

ja.ma/4pkRxHW
July 16, 2026 at 10:00 AM
Meta-analysis: #Centiloid values <11 or >26 on #AmyloidPET scans provide high diagnostic confidence for the absence or presence of amyloid in #AlzheimerDisease, while values between 11 and 26 indicates uncertainty and may require further assessment. #AAIC26

ja.ma/3RxLxz6
July 13, 2026 at 3:05 PM
So proud of and grateful for present and past @hwameeohlab.bsky.social members and collaborators who made us become the #FIRST lab to perform #amyloidPET and #tauPET scans through Brown University !
April 15, 2026 at 8:34 PM
So proud of and grateful for present and past @hwameeohlab.bsky.social members and collaborators who made us become the #FIRST lab to perform #amyloidPET and #tauPET scans through Brown University !
November 18, 2024 at 11:42 AM
We still need your input for our our survey about #AmyloidPET imaging across Europe! 🧠

⏰ Participate by July 14 (deadline extended)

Find out more below 👇
Take part in our survey about #AmyloidPET imaging across Europe! 🧠

📝 Just 11 questions – takes 2–4 minutes
🔒 Fully confidential – no institutions or individuals will be named
📈 Results will be published in aggregated statistical form

👉 committeemeeting.questionpro.com/t/AKfvuZ6GAA
EANM - Amyloid PET survey We invite you to participate in a brief survey aimed at improving the reimbursement of amyloid PET imaging across Europe. Your input is highly valuable and will help inform efforts to enhance access to this important diagnostic tool. The survey consists of only  11 questions . It will take approximately  2 to 4 minutes  to complete, Your responses will contribute directly to shaping future policy and reimbursement frameworks. The survey is aimed at the direction of nuclear medicine facilities (delegation is possible) and refers exclusively to routine clinical examinations (no research applications). The questions refer to the current, routine situation in your facility. Multiple answers are possible. Otherwise, only one answer should be provided. The questionnaires will be collected by the EANM and analyzed by the research group of Igor Yakushev, Technical University of Munich, Germany. The questionnaires will not be passed on to other persons, institutions, or companies. Results of the survey will be published in cumulative/statistical form (mean values, standard deviation, p-values, etc.). Participants of the survey or institutions will not be named. Responses of individual institutions will not be published. After the publication of the results, all questionnaires will be deleted. Until the time of publication, each participant can withdraw the questionnaire without providing any reason. Thank you in advance for your time and support!  
EANM - Amyloid PET survey We invite you to participate in a brief survey aimed at improving the reimbursement of amyloid PET imaging across Europe. Your input is highly valuable and will help inform efforts to enhance access to this important diagnostic tool. The survey consists of only  11 questions . It will take approximately  2 to 4 minutes  to complete, Your responses will contribute directly to shaping future policy and reimbursement frameworks. The survey is aimed at the direction of nuclear medicine facilities (delegation is possible) and refers exclusively to routine clinical examinations (no research applications). The questions refer to the current, routine situation in your facility. Multiple answers are possible. Otherwise, only one answer should be provided. The questionnaires will be collected by the EANM and analyzed by the research group of Igor Yakushev, Technical University of Munich, Germany. The questionnaires will not be passed on to other persons, institutions, or companies. Results of the survey will be published in cumulative/statistical form (mean values, standard deviation, p-values, etc.). Participants of the survey or institutions will not be named. Responses of individual institutions will not be published. After the publication of the results, all questionnaires will be deleted. Until the time of publication, each participant can withdraw the questionnaire without providing any reason. Thank you in advance for your time and support!  
committeemeeting.questionpro.com
June 25, 2025 at 8:04 AM
Take part in our survey about #AmyloidPET imaging across Europe! 🧠

📝 Just 11 questions – takes 2–4 minutes
🔒 Fully confidential – no institutions or individuals will be named
📈 Results will be published in aggregated statistical form

👉 committeemeeting.questionpro.com/t/AKfvuZ6GAA
EANM - Amyloid PET survey We invite you to participate in a brief survey aimed at improving the reimbursement of amyloid PET imaging across Europe. Your input is highly valuable and will help inform efforts to enhance access to this important diagnostic tool. The survey consists of only  11 questions . It will take approximately  2 to 4 minutes  to complete, Your responses will contribute directly to shaping future policy and reimbursement frameworks. The survey is aimed at the direction of nuclear medicine facilities (delegation is possible) and refers exclusively to routine clinical examinations (no research applications). The questions refer to the current, routine situation in your facility. Multiple answers are possible. Otherwise, only one answer should be provided. The questionnaires will be collected by the EANM and analyzed by the research group of Igor Yakushev, Technical University of Munich, Germany. The questionnaires will not be passed on to other persons, institutions, or companies. Results of the survey will be published in cumulative/statistical form (mean values, standard deviation, p-values, etc.). Participants of the survey or institutions will not be named. Responses of individual institutions will not be published. After the publication of the results, all questionnaires will be deleted. Until the time of publication, each participant can withdraw the questionnaire without providing any reason. Thank you in advance for your time and support!  
EANM - Amyloid PET survey We invite you to participate in a brief survey aimed at improving the reimbursement of amyloid PET imaging across Europe. Your input is highly valuable and will help inform efforts to enhance access to this important diagnostic tool. The survey consists of only  11 questions . It will take approximately  2 to 4 minutes  to complete, Your responses will contribute directly to shaping future policy and reimbursement frameworks. The survey is aimed at the direction of nuclear medicine facilities (delegation is possible) and refers exclusively to routine clinical examinations (no research applications). The questions refer to the current, routine situation in your facility. Multiple answers are possible. Otherwise, only one answer should be provided. The questionnaires will be collected by the EANM and analyzed by the research group of Igor Yakushev, Technical University of Munich, Germany. The questionnaires will not be passed on to other persons, institutions, or companies. Results of the survey will be published in cumulative/statistical form (mean values, standard deviation, p-values, etc.). Participants of the survey or institutions will not be named. Responses of individual institutions will not be published. After the publication of the results, all questionnaires will be deleted. Until the time of publication, each participant can withdraw the questionnaire without providing any reason. Thank you in advance for your time and support!  
committeemeeting.questionpro.com
May 22, 2025 at 6:00 AM